Free Trial
NASDAQ:OKYO

OKYO Pharma (OKYO) Stock Price, News & Analysis

OKYO Pharma logo
$1.18
+0.01 (+0.85%)
(As of 10/31/2024 ET)

About OKYO Pharma Stock (NASDAQ:OKYO)

Key Stats

Today's Range
$1.13
$1.20
50-Day Range
$0.95
$1.33
52-Week Range
$0.81
$2.12
Volume
120,140 shs
Average Volume
129,907 shs
Market Capitalization
$39.93 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00
Consensus Rating
Buy

Company Overview

OKYO Pharma Limited, a clinical-stage biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead preclinical product candidate is OK-101, which is in Phase II clinical trials for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic chronic pain. The company was incorporated in 2007 and is headquartered in London, the United Kingdom.

OKYO Pharma Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
71st Percentile Overall Score

OKYO MarketRank™: 

OKYO Pharma scored higher than 71% of companies evaluated by MarketBeat, and ranked 352nd out of 993 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    OKYO Pharma has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    OKYO Pharma has only been the subject of 1 research reports in the past 90 days.

  • Read more about OKYO Pharma's stock forecast and price target.
  • Earnings Growth

    Earnings for OKYO Pharma are expected to grow in the coming year, from ($0.40) to ($0.38) per share.

  • Percentage of Shares Shorted

    0.76% of the float of OKYO Pharma has been sold short.
  • Short Interest Ratio / Days to Cover

    OKYO Pharma has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in OKYO Pharma has recently decreased by 11.54%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    OKYO Pharma does not currently pay a dividend.

  • Dividend Growth

    OKYO Pharma does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.76% of the float of OKYO Pharma has been sold short.
  • Short Interest Ratio / Days to Cover

    OKYO Pharma has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in OKYO Pharma has recently decreased by 11.54%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    OKYO Pharma has a news sentiment score of 0.79. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.68 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for OKYO Pharma this week, compared to 1 article on an average week.
  • MarketBeat Follows

    1 people have added OKYO Pharma to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, OKYO Pharma insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    40.46% of the stock of OKYO Pharma is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 2.97% of the stock of OKYO Pharma is held by institutions.

  • Read more about OKYO Pharma's insider trading history.
Receive OKYO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OKYO Pharma and its competitors with MarketBeat's FREE daily newsletter.

OKYO Stock News Headlines

The real reason Elon is fully endorsing Trump
Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump.
OKYO Pharma (NASDAQ:OKYO) Earns Buy Rating from HC Wainwright
Q2 EPS Estimates for OKYO Pharma Decreased by HC Wainwright
See More Headlines

OKYO Stock Analysis - Frequently Asked Questions

OKYO Pharma's stock was trading at $1.77 at the start of the year. Since then, OKYO stock has decreased by 33.3% and is now trading at $1.18.
View the best growth stocks for 2024 here
.

OKYO Pharma (OKYO) raised $2 million in an initial public offering (IPO) on Tuesday, May 17th 2022. The company issued 625,000 shares at a price of $4.00 per share.

Shares of OKYO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that OKYO Pharma investors own include Meta Platforms (META), Intel (INTC), NVIDIA (NVDA), C3.ai (AI), Bristol-Myers Squibb (BMY), Energy Transfer (ET) and Ford Motor (F).

Company Calendar

Today
10/31/2024
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:OKYO
Fax
N/A
Employees
7
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$7.00
High Stock Price Target
$7.00
Low Stock Price Target
$7.00
Potential Upside/Downside
+500.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($0.20) per share

Miscellaneous

Free Float
20,146,000
Market Cap
$39.42 million
Optionable
Not Optionable
Beta
-0.06
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:OKYO) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners